This was linked to reduced sensitivity to 5-fluorouracil (5-FU), suggesting that the ARID3A-to-AKR1C3 ratio could be a useful prognostic marker for CRC patients undergoing chemotherapy [210]. The gene discussed is ARID3A; the disease is colorectal carcinoma.